Acute Treatment for Migraine: Contemporary Treatments and Future Directions

Affiliations

¹ Graham Headache Center, Brigham and Women's Hospital Department of Neurology, Harvard Medical School, Boston, Massachusetts.
² Department of Neurology, University at Buffalo, State University of New York, Buffalo, New York.

Editorial

Rebecca Burch et al. JAMA. 2021.

. 2021 Jun 15;325(23):2346-2347.

doi: 10.1001/jama.2021.7275.

¹ Graham Headache Center, Brigham and Women's Hospital Department of Neurology, Harvard Medical School, Boston, Massachusetts.
² Department of Neurology, University at Buffalo, State University of New York, Buffalo, New York.

No abstract available

Comment on

Acute Treatments for Episodic Migraine in Adults: A Systematic Review and Meta-analysis.
VanderPluym JH, Halker Singh RB, Urtecho M, Morrow AS, Nayfeh T, Torres Roldan VD, Farah MH, Hasan B, Saadi S, Shah S, Abd-Rabu R, Daraz L, Prokop LJ, Murad MH, Wang Z. VanderPluym JH, et al. JAMA. 2021 Jun 15;325(23):2357-2369. doi: 10.1001/jama.2021.7939. JAMA. 2021. PMID: 34128998 Free PMC article.
Effects of Intravenous Eptinezumab vs Placebo on Headache Pain and Most Bothersome Symptom When Initiated During a Migraine Attack: A Randomized Clinical Trial.
Winner PK, McAllister P, Chakhava G, Ailani J, Ettrup A, Krog Josiassen M, Lindsten A, Mehta L, Cady R. Winner PK, et al. JAMA. 2021 Jun 15;325(23):2348-2356. doi: 10.1001/jama.2021.7665. JAMA. 2021. PMID: 34128999 Free PMC article. Clinical Trial.

Level of therapeutic innovation from the registration studies of the new drugs for the prophylaxis of migraine.
Motola D, Santi Laurini G, Bonaldo G, Montanaro N. Motola D, et al. J Clin Pharm Ther. 2022 Dec;47(12):2130-2139. doi: 10.1111/jcpt.13760. Epub 2022 Aug 19. J Clin Pharm Ther. 2022. PMID: 36054749 Free PMC article.